Amox%252525252525252525252525252520cv

# Amoxicillin-Clavulanate ## Overview Amoxicillin-clavulanate is a combination aminopenicillin antibiotic and beta-lactamase inhibitor. The addition of clavulanic acid extends the spectrum of activity to include beta-lactamase-producing strains of *S. aureus*, *H. influenzae*, *M. catarrhalis*, and certain anaerobes. ## Primary Indications Commonly used for acute bacterial rhinosinusitis, community-acquired pneumonia, animal/human bites, skin and soft tissue infections, and urinary tract infections. ## Adult Dosing Standard dosing is typically based on the amoxicillin component. * **Mild to moderate severity:** 500 mg orally every 8 hours or 875 mg orally every 12 hours. * **Severe infections:** 875 mg orally every 8 hours (using extended-release formulations or multiple tablets). * **Note:** Due to the clavulanate content, do not use two 875 mg tablets to achieve a higher dose; this results in excessive clavulanate, which may cause GI distress. ## Pediatric Dosing **Dosing should be based on weight and the specific formulation ratio.** Pediatric formulations come in various ratios (e.g., 4:1, 7:1); always verify the ratio on the prescription. * **Standard dose:** 25–45 mg/kg/day (based on amoxicillin component) divided every 12 hours. * **Severe/Recurrent infections (e.g., Acute Otitis Media):** 80–90 mg/kg/day divided every 12 hours (often using the 600 mg/5 mL formulation to minimize clavulanate exposure). * **Maximum:** Follow specific age/weight-based recommendations; generally capped at adult maximums. ## Dose Adjustments * **Renal Impairment:** If CrCl < 30 mL/min, the use of extended-release formulations is generally contraindicated. Reduce frequency or dose based on CrCl level; avoid specific formulations (e.g., 875 mg) in severe renal impairment. * **Hepatic Impairment:** Use with caution; monitor hepatic function. ## Contraindications * History of serious hypersensitivity (anaphylaxis) to any penicillin. * History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin-clavulanate. ## Adverse Effects * **Gastrointestinal:** Diarrhea (very common), nausea, and vomiting. Administer with food to minimize GI upset. * **Hepatic:** Potential for drug-induced hepatitis or cholestatic jaundice (more common in males and the elderly). * **Dermatologic:** Rash (specifically non-allergic maculopapular rash, often seen in EBV infections). * **Other:** Superinfection (C. difficile-associated diarrhea, candidiasis). ## Key Drug Interactions * **Warfarin:** May increase INR and bleeding risk; monitor INR closely. * **Methotrexate:** May decrease clearance of methotrexate, increasing toxicity. * **Oral Contraceptives:** May reduce efficacy; suggest backup contraception during therapy. ## Monitoring * **Signs of hypersensitivity:** Anaphylaxis or severe skin reactions. * **Renal/Hepatic:** Periodic baseline and follow-up LFTs and renal function tests if long-term therapy is required. * **GI:** Monitor for severe diarrhea or persistent bloody stools (potential *C. difficile*). ## Clinical Pearls * **Clavulanate Ratio:** Use the 600 mg/5 mL oral suspension for high-dose pediatric therapy to reduce the total amount of clavulanate administered, which significantly reduces the incidence of diarrhea. * **Food:** Always advise patients to take the medication at the start of a meal to improve absorption and reduce GI side effects. * **Allergy:** A history of a mild "rash" to penicillin in childhood may not be a true IgE-mediated allergy; consider referral for penicillin allergy testing if the history is ambiguous. *** **Educational Disclaimer:** This summary is for informational purposes only and does not constitute medical advice. Dosing and clinical decisions should be based on institutional protocols, updated guidelines (e.g., IDSA/AAP), and the manufacturers' current prescribing information. Always verify dosing calculations and patient-specific factors before prescribing or administering medication.